Revolutionizing Breast Cancer Prediction with EarlyTrace's AI Solutions
Breast cancer is a devastating disease that affects millions of women around the world. Early detection plays a crucial role in...
top of page
Impact of early breast cancer detection solution
1 in 8
Breast cancer diagnosis in a women’s lifetime¹
39%
Combined Breast cancer screening deficit in Europe. EE at 51%²
36%
# mortality reduction with early screening availability per year.³
Our Solution
Screening for breast cancer
with a blood sample.
Innovative Proteomics Approach
Our cutting-edge solution leverages specific protein biomarkers to analyse protein patterns in blood samples, identifying early signs of breast cancer.
Detecting cancer-specific proteins in the patient's blood combined with AI, our solution enables early intervention, increasing the chances of successful treatment.
Simple, Non-Invasive Process
Our radiation-free AI-powered analysis, using just a blood sample, provides highly accurate predictions of breast cancer sensitivity.
Early Intervention
The entire analysis process aims to take 2 weeks, from the arrival of the blood sample at the specialised earlytrace laboratory to the availability of the result.
Latest Articles
Meet our Team
We are a diverse team united by a shared passion for advancing digital innovation in cancer detection. Our commitment is to be at the forefront of new technologies to transform patient outcomes and improve lives.
Dr. Nicole Schneiderhan-Marra
20+ years experience in biomarker research and bioanalytical test development, providing services for pharma and academics and group/ department management.
Marc Mausch
20+ years of technology business experience across several industries, and successfully founded and established a Telemed company.
Dr.Jens Göpfert
15+ years of experience in biomarker research and ultrasensitive immunoassay development, providing GCP-compliant analysis of clinical trial samples to pharmaceutical companies, and project and group management.
Sofiane Ouaari
5+ years of experience developing Machine Learning applications and Data Analytics solutions in various domains, including FinTech, NLP/NLG and Healthcare.
Ifeoma Wulz
Ex-founder with 15 years of experience in growth marketing and commercialisation across several industries, from Tech to global cooperations.
References
1- for Europe only source: Institutional agency for research cancer (WHO). https://gco.iarc.fr/today/en/dataviz/maps-heatmap?mode=population&cancers=20&zoom=5
2- Europe only. EE is leading with 51%, and SE = 31%. Int J Cancer. 2021 Jan 15; 148(2): 406–418. Published online 2020 Jul 30. doi: 10.1002/ijc.3320 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754503/
3- Europe only with 100% coverage, 12 434 additional breast cancer deaths could be prevented annually. source: PubMed- www.ncbi.nlm.nih
Contact us
contact[at]earlytrace.com
bottom of page